Lumito
6.65 SEK
-7.38 %
Less than 1K followers
LUMITO
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-7.38 %
-21.76 %
-5.00 %
-70.44 %
-92.11 %
-93.74 %
-98.03 %
-99.41 %
-97.27 %
Lumito is a Swedish company that develops and markets systems for tissue and biomarker analysis in digital pathology, built on upconverting nanoparticle technology. The company targets healthcare facilities, research and the pharmaceutical sector. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito is headquartered in Lund.
Read moreMarket cap
22.88M SEK
Turnover
50.32K SEK
Revenue
100K
EBIT %
-38,300 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20/2
2026
Annual report '25
7/5
2026
General meeting '26
7/5
2026
Interim report Q1'26
All
Press releases
3rd party
ShowingAll content types
Lumito AB publishes year-end report 2025
Lumito and Atlas Antibodies enter strategic partnership to advance high-resolution tissue imaging
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools